Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March [Yahoo! Finance]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in March as follows: Barclays th Annual Global Healthcare Conference Tuesday, March 11, 2025, at 8:00 am ET Leerink Partners Global Healthcare Conference Wednesday, March 12, 2025, at 8:40 am ET To access a live webcast of the presentation, visit Teva's Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations An archived version of the webcast will be available within 24 hours after the end of the live discussion. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global pharmaceutical leader, one that operates across the full spectrum of in
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry PharmaPR Newswire
- Lumicera Secures Purchase Agreement for Stelara® Biosimilar, Delivering Major Cost Savings [Yahoo! Finance]Yahoo! Finance
- Teva Pharmaceutical Industries Limited (NYSE: TEVA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target lowered by analysts at Bank of America Co. from $23.00 to $20.00. They now have a "buy" rating on the stock.MarketBeat
- United States Lidocaine Patches Market Report 2024 with Long-term Outlook, Competitive Landscape of Amneal, Endo, Hisamitsu, Medline, Scilex, Sparsha, Teikoku, Teva, Viatris, and YARAL [Yahoo! Finance]Yahoo! Finance
TEVA
Earnings
- 1/29/25 - Beat
TEVA
Sec Filings
- 3/7/25 - Form 4
- 3/7/25 - Form 4
- 3/7/25 - Form 4
- TEVA's page on the SEC website